Mendelian etiologies identified with whole exome sequencing in cerebral palsy.
Journal
Annals of clinical and translational neurology
ISSN: 2328-9503
Titre abrégé: Ann Clin Transl Neurol
Pays: United States
ID NLM: 101623278
Informations de publication
Date de publication:
02 2022
02 2022
Historique:
revised:
15
12
2021
received:
16
11
2021
accepted:
15
12
2021
pubmed:
26
1
2022
medline:
17
3
2022
entrez:
25
1
2022
Statut:
ppublish
Résumé
Cerebral palsy (CP) is the most common childhood motor disability, yet its link to single-gene disorders is under-characterized. To explore the genetic landscape of CP, we conducted whole exome sequencing (WES) in a cohort of patients with CP. We performed comprehensive phenotyping and WES on a prospective cohort of individuals with cryptogenic CP (who meet criteria for CP; have no risk factors), non-cryptogenic CP (who meet criteria for CP; have at least one risk factor), and CP masqueraders (who could be diagnosed with CP, but have regression/progressive symptoms). We characterized motor phenotypes, ascertained medical comorbidities, and classified brain MRIs. We analyzed WES data using an institutional pipeline. We included 50 probands in this analysis (20 females, 30 males). Twenty-four had cryptogenic CP, 20 had non-cryptogenic CP, five had CP masquerader classification, and one had unknown classification. Hypotonic-ataxic subtype showed a difference in prevalence across the classification groups (p = 0.01). Twenty-six percent of participants (13/50) had a pathogenic/likely pathogenic variant in 13 unique genes (ECHS1, SATB2, ZMYM2, ADAT3, COL4A1, THOC2, SLC16A2, SPAST, POLR2A, GNAO1, PDHX, ACADM, ATL1), including one patient with two genetic disorders (ACADM, PDHX) and two patients with a SPAST-related disorder. The CP masquerader category had the highest diagnostic yield (n = 3/5, 60%), followed by the cryptogenic CP category (n = 7/24, 29%). Fifteen percent of patients with non-cryptogenic CP (n = 3/20) had a Mendelian disorder on WES. WES demonstrated a significant prevalence of Mendelian disorders in individuals clinically diagnosed with CP, including in individuals with known CP risk factors.
Identifiants
pubmed: 35076175
doi: 10.1002/acn3.51506
pmc: PMC8862420
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
193-205Subventions
Organisme : NICHD NIH HHS
ID : P50 HD105351
Pays : United States
Organisme : NINDS NIH HHS
ID : 2R25NS070682
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS106298
Pays : United States
Organisme : NINDS NIH HHS
ID : 1K08NS123552-01
Pays : United States
Organisme : NINDS NIH HHS
ID : K23 NS119666
Pays : United States
Informations de copyright
© 2022 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.
Références
Pediatrics. 2021 Feb;147(2):
pubmed: 33402528
JAMA. 2021 Feb 2;325(5):467-475
pubmed: 33528536
Am J Hum Genet. 2020 Aug 6;107(2):352-363
pubmed: 32693025
Nat Genet. 2020 Oct;52(10):1046-1056
pubmed: 32989326
Clin Perinatol. 2016 Sep;43(3):559-72
pubmed: 27524454
Neuromolecular Med. 2014 Dec;16(4):821-44
pubmed: 25280894
Nat Methods. 2010 Apr;7(4):248-9
pubmed: 20354512
Orphanet J Rare Dis. 2014 Nov 30;9:197
pubmed: 25433678
Neurology. 2020 Nov 24;95(21):962-972
pubmed: 33046609
Mol Psychiatry. 2015 Feb;20(2):176-82
pubmed: 25666757
Am J Hum Genet. 2020 Oct 1;107(4):727-742
pubmed: 32891193
Neurology. 2019 Jul 2;93(1):e88-e96
pubmed: 31127072
Obstet Gynecol. 2013 Jul;122(1):41-49
pubmed: 23743468
J Child Neurol. 2019 Jul;34(8):472-476
pubmed: 30963790
Int J Stroke. 2008 Aug;3(3):169-72
pubmed: 18705894
NPJ Genom Med. 2018 Dec 14;3:33
pubmed: 30564460
J Pediatr. 2017 Feb;181:267-271.e1
pubmed: 27816221
Neurology. 2009 Jun 16;72(24):2090-6
pubmed: 19528515
Dev Med Child Neurol Suppl. 2007 Feb;109:8-14
pubmed: 17370477
Neurology. 2015 Apr 21;84(16):1660-8
pubmed: 25817843
Nucleic Acids Res. 2012 Jul;40(Web Server issue):W452-7
pubmed: 22689647
Lancet Neurol. 2020 Nov;19(11):908-918
pubmed: 33098801
Dev Med Child Neurol. 2007 Feb;49(s109):1-44
pubmed: 17371509
Ann Neurol. 2014 Oct;76(4):473-83
pubmed: 25131622
Nat Commun. 2015 Aug 03;6:7949
pubmed: 26236009
Ann Clin Transl Neurol. 2018 Mar 26;5(5):538-551
pubmed: 29761117
Pediatrics. 2015 Dec;136(6):1132-43
pubmed: 26598455
Pediatr Neurol. 2016 Apr;57:74-9
pubmed: 26857522
Am Fam Physician. 2006 Jan 1;73(1):91-100
pubmed: 16417071
Dev Med Child Neurol. 2021 Dec;63(12):1448-1455
pubmed: 34114234
J Mol Diagn. 2017 Jan;19(1):4-23
pubmed: 27993330
J Med Genet. 2021 Jul 28;:
pubmed: 34321325
NPJ Genom Med. 2020 Jul 6;5:29
pubmed: 32655885
J Matern Fetal Neonatal Med. 2012 Jan;25(1):53-7
pubmed: 21463212
Pediatrics. 2014 Jan;133(1):55-62
pubmed: 24379238
Eur J Hum Genet. 2014 Jan;22(1):40-5
pubmed: 23695280
Brain. 2015 Jul;138(Pt 7):1817-32
pubmed: 25981959